Literature DB >> 22572774

Increased prevalence of anxiety-associated personality traits in patients with Cushing's disease: a cross-sectional study.

C Dimopoulou1, M Ising, H Pfister, J Schopohl, G K Stalla, C Sievers.   

Abstract

BACKGROUND/AIMS: Chronic hypercortisolism in Cushing's disease (CD) has been suggested to contribute to an altered personality profile in these patients. We aimed to test this hypothesis and attempted to determine the effects of disease- and treatment-related factors that might moderate an altered personality in CD.
METHODS: We assessed 50 patients with CD (74% biochemically controlled) and compared them to 60 patients with non-functioning pituitary adenomas (NFPA) and 100 age- and gender-matched mentally healthy controls. Personality was measured by two standardized personality questionnaires, TPQ (Cloninger personality questionnaire) and EPQ-RK (Eysenck personality questionnaire-RK).
RESULTS: Compared to mentally healthy controls, CD patients reported significantly less novelty-seeking behaviour, including less exploratory excitability and less extravagance. On harm avoidant subscales, they presented with more anticipatory worries and pessimism, higher fear of uncertainty, shyness with strangers, fatigability and asthenia. Moreover, CD patients appeared to be less extraverted, more neurotic and socially desirable. CD patients differed from NFPA patients in terms of higher neuroticism scores, and NFPA patients did not show altered novelty-seeking behaviour or extraversion. In the subgroup analysis, CD patients with persistent hypercortisolism displayed significantly higher fear of uncertainty, fatigability and asthenia, indicating high harm avoidance in total, than those in biochemical remission.
CONCLUSION: Patients with CD showed a distinct pattern of personality traits associated with high anxiety in combination with traits of low externalizing behaviour. Such personality changes should be taken into account in the diagnosis and treatment of CD patients, as they might interfere with the patient-physician communication and/or challenge the patients' social and psychological functioning.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22572774     DOI: 10.1159/000338408

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  12 in total

1.  Glucocorticoid receptor deletion from the dorsal raphé nucleus of mice reduces dysphoria-like behavior and impairs hypothalamic-pituitary-adrenocortical axis feedback inhibition.

Authors:  Melanie Y Vincent; Lauren Jacobson
Journal:  Eur J Neurosci       Date:  2014-03-29       Impact factor: 3.386

Review 2.  Quality of life in Cushing's syndrome.

Authors:  Alicia Santos; Iris Crespo; Anna Aulinas; Eugenia Resmini; Elena Valassi; Susan M Webb
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

Review 3.  Clinical and biochemical manifestations of Cushing's.

Authors:  Georgia Ntali; Ashley Grossman; Niki Karavitaki
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

Review 4.  Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.

Authors:  Alicia Santos; Eugenia Resmini; Juan Carlos Pascual; Iris Crespo; Susan M Webb
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

Review 5.  Cushing's disease: the burden of illness.

Authors:  Rosario Pivonello; Maria Cristina De Martino; Monica De Leo; Chiara Simeoli; Annamaria Colao
Journal:  Endocrine       Date:  2016-05-17       Impact factor: 3.633

Review 6.  Cushing's Disease - Quality of Life, Recurrence and Long-term Morbidity.

Authors:  Isabel Huguet; Georgia Ntali; Ashley Grossman; Niki Karavitaki
Journal:  Eur Endocrinol       Date:  2015-04-11

7.  Neuropsychiatric and cardiometabolic comorbidities in patients with previously diagnosed Cushing's disease: a longitudinal observational study.

Authors:  C Dimopoulou; V Geraedts; G K Stalla; C Sievers
Journal:  BMJ Open       Date:  2015-03-27       Impact factor: 2.692

8.  Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome.

Authors:  Scott J Moeller; Lizette Couto; Vanessa Cohen; Yelena Lalazar; Iouri Makotkine; Nia Williams; Rachel Yehuda; Rita Z Goldstein; Eliza B Geer
Journal:  Front Neurosci       Date:  2016-02-05       Impact factor: 4.677

9.  Hyperactivity of Hypothalamic-Pituitary-Adrenal Axis Due to Dysfunction of the Hypothalamic Glucocorticoid Receptor in Sigma-1 Receptor Knockout Mice.

Authors:  Tingting Di; Suyun Zhang; Juan Hong; Tingting Zhang; Ling Chen
Journal:  Front Mol Neurosci       Date:  2017-09-06       Impact factor: 5.639

10.  Basomedial amygdala mediates top-down control of anxiety and fear.

Authors:  Avishek Adhikari; Talia N Lerner; Joel Finkelstein; Sally Pak; Joshua H Jennings; Thomas J Davidson; Emily Ferenczi; Lisa A Gunaydin; Julie J Mirzabekov; Li Ye; Sung-Yon Kim; Anna Lei; Karl Deisseroth
Journal:  Nature       Date:  2015-11-04       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.